Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Browse Other Projects on Experiment
Related Projects
Developing a novel oxysterol antibiotic to combat drug-resistant tuberculosis
Drug-resistant tuberculosis (TB) is a consistently growing threat to global health. We have developed Oxy291...
Postpartum Mental Health Needs of Hispanic Mothers
Postpartum mood disorders represent a critical public health issue affecting mothers and their children...
Assessing Guadalupe Fur Seal Health and Ecology
A multidisciplinary team of researchers will assess the health of Guadalupe fur seal pups and adults by...